335 related articles for article (PubMed ID: 26890738)
1. A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.
Granger MW; Franko B; Taylor MW; Messier C; George-Hyslop PS; Bennett SA
J Alzheimers Dis; 2016; 51(3):757-73. PubMed ID: 26890738
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
5. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease.
King DL; Arendash GW; Crawford F; Sterk T; Menendez J; Mullan MJ
Behav Brain Res; 1999 Sep; 103(2):145-62. PubMed ID: 10513583
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Study Evaluating the Impact of Physical Exercise on Disease Progression in a Mouse Model of Alzheimer's Disease.
Maliszewska-Cyna E; Xhima K; Aubert I
J Alzheimers Dis; 2016 May; 53(1):243-57. PubMed ID: 27163797
[TBL] [Abstract][Full Text] [Related]
7. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
8. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
Doggui S; Brouillette J; Chabot JG; Farso M; Quirion R
Neurodegener Dis; 2010; 7(1-3):88-95. PubMed ID: 20173334
[TBL] [Abstract][Full Text] [Related]
10. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
Fragkouli A; Tsilibary EC; Tzinia AK
Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR
J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545
[TBL] [Abstract][Full Text] [Related]
13. Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression.
Polito L; Chierchia A; Tunesi M; Bouybayoune I; Kehoe PG; Albani D; Forloni G
J Alzheimers Dis; 2014; 42(3):851-64. PubMed ID: 24961946
[TBL] [Abstract][Full Text] [Related]
14. Entorhinal Cortical Deep Brain Stimulation Rescues Memory Deficits in Both Young and Old Mice Genetically Engineered to Model Alzheimer's Disease.
Xia F; Yiu A; Stone SSD; Oh S; Lozano AM; Josselyn SA; Frankland PW
Neuropsychopharmacology; 2017 Dec; 42(13):2493-2503. PubMed ID: 28540926
[TBL] [Abstract][Full Text] [Related]
15. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease.
Lovasic L; Bauschke H; Janus C
Genes Brain Behav; 2005 Apr; 4(3):197-208. PubMed ID: 15810906
[TBL] [Abstract][Full Text] [Related]
16. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
[TBL] [Abstract][Full Text] [Related]
17. Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.
Couch BA; Kerrisk ME; Kaufman AC; Nygaard HB; Strittmatter SM; Koleske AJ
J Comp Neurol; 2013 Apr; 521(6):1395-408. PubMed ID: 23047754
[TBL] [Abstract][Full Text] [Related]
18. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
19. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]